Sleep Disorder Market Size, Share, Growth – By Disorder Type, By Product, By End Use – Global Forecast, 2025 to 2034

The global sleep disorder industry was valued at USD 27.6 billion in 2024 and is expected to grow at a CAGR of 10.1% from 2025 to 2034, driven by the increasing prevalence of sleep disorders and rising demand for advanced devices.

Key players in the industry include Apple Inc., Asahi Kasei Corporation, BMC Medical, Cadwell Laboratories, Drive DeVilbiss International, Fisher & Paykel Healthcare, Fitbit I, Koninklijke Philips N.V., LivaNova, Natus Medical, Nihon Kohden, and Oura Health.

The North America sleep disorder market recorded USD 10.6 billion in revenue in 2024 and is anticipated to grow at a CAGR of 9.6% between 2025 and 2034, driven by a large population affected by sleep disorders.

The therapeutics segment is projected to expand at a 10.5% CAGR, reaching over USD 47.2 billion by 2034, due to technological advancements in therapeutic devices, particularly for sleep apnea.